Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system

被引：0
|
作者：
Mark N. Kirstein
Richard C. Brundage
Megan M. Moore
Brent W. Williams
Lisa A. Hillman
Jason W. Dagit
James E. Fisher
Paul H. Marker
Robert A. Kratzke
Douglas Yee
机构：
[1] University of Minnesota,Department of Experimental and Clinical Pharmacology, College of Pharmacy and Comprehensive Cancer Center
[2] University of Minnesota,Department of Experimental and Clinical Pharmacology, College of Pharmacy
[3] University of Minnesota,Clinical Pharmacology Analytical Services
[4] University of Minnesota,Department of Medicine and Stem Cell Institute
[5] University of Minnesota,Department of Medicine and Cancer Center
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Gemcitabine; Bioreactor; SubG1; MDA-MB-231 cells; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 299
页数：8
相关论文
共 50 条
  • [1] Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system
    Kirstein, Mark N.
    Brundage, Richard C.
    Moore, Megan M.
    Williams, Brent W.
    Hillman, Lisa A.
    Dagit, Jason W.
    Fisher, James E.
    Marker, Paul H.
    Kratzke, Robert A.
    Yee, Douglas
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 291 - 299
  • [2] Endpoint determination for gemcitabine treatment in the in vitro cell culture bioreactor system
    Kirstein, Mark N.
    Brundage, Richard C.
    Moore, Megan M.
    Hillman, Lisa A.
    Marker, Paul H.
    Kratzke, Robert A.
    Yee, Doug
    CANCER RESEARCH, 2006, 66 (08)
  • [3] Short versus continuous gemcitabine treatment of non-small cell lung cancer in an in vitro cell culture bioreactor system
    Kirstein, Mark N.
    Wieman, Katie M.
    Williams, Brent W.
    Fisher, James E.
    Marker, Paul H.
    Le, Chap T.
    Yee, Douglas
    Kratzke, Robert A.
    LUNG CANCER, 2007, 58 (02) : 196 - 204
  • [4] Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens
    Kirstein, MN
    Brundage, RC
    Elmquist, WF
    Remmel, RP
    Marker, PH
    Guire, DE
    Yee, D
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 96 (03) : 217 - 225
  • [5] Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens
    Mark N. Kirstein
    Richard C. Brundage
    William F. Elmquist
    Rory P. Remmel
    Paul H. Marker
    Dan E. Guire
    Douglas Yee
    Breast Cancer Research and Treatment, 2006, 96 : 217 - 225
  • [6] Analysis "in vitro" of cytotoxicity of Carisolv in cell culture
    Santos, EM
    Bussadori, SK
    Jaeger, MMM
    Guedes-Pinto, AC
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1009 - 1009
  • [7] The impact of oxygen deficiency on cell characteristics and on the cytotoxicity of gemcitabine: In vitro data
    Wouters, An
    Pauwels, Bea
    Lambrechts, Hilde A. J.
    Pattyn, Greet G. O.
    Vermorken, Jan B.
    Lar-Don, Filip
    ACTA CLINICA BELGICA, 2008, 63 (02): : 132 - 132
  • [8] CELLIGEN - A NOVEL CELL-CULTURE BIOREACTOR SYSTEM
    KRUGER, B
    DECHEMA BIOTECHNOLOGY CONFERENCES, VOL 3, PTS A AND B, 1989, 3 : 723 - 725
  • [9] Preparation, characterization, cytotoxicity and pharmacokinetics of niosomes containing gemcitabine: In vitro, in vivo, and simulation studies
    Barani, Mahmood
    Hajinezhad, Mohammad Reza
    Zargari, Farshid
    Shahraki, Sheida
    Davodabadi, Fatemeh
    Mirinejad, Shekoufeh
    Sargazi, Saman
    Rahdar, Abbas
    Diez-Pascual, Ana M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 84
  • [10] Analysis in vitro of cytotoxicity of iodoform pastes in cell culture.
    Santos, EM
    Jaeger, MMM
    Guedes-Pinto, AC
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1023 - 1023
12345